• PNS201 MEASUREMENT COMPARABILITY OF ELECTRONIC AND PAPER ADMINISTERED VISUAL ANALOGUE SCALES: A REVIEW OF PUBLISHED STUDIES

    May 1, 2019, 00:00

  • PDB68 DEMOGRAPHIC AND CLINICAL PROFILES OF PATIENTS WITH TYPE 2 DIABETES NEWLY INITIATING SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS COMPARED TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS

    May 1, 2019, 00:00

  • PNS248 THE INVOLVEMENT OF PATIENTS IN THE REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS

    May 1, 2019, 00:00

  • PMD43 PRE-OPERATIVE PREDICTORS OF POST-OPERATIVE PAIN RELIEF: PAIN SCORE MODELING FOLLOWING TOTAL KNEE ARTHROPLASTY

    May 1, 2019, 00:00

  • PNS42 R NICE LAGGING BEHIND THE WORLD?

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Economic Evaluation

    May 1, 2019, 00:00

  • PND70 ASSESSMENT OF MIGRAINE PROGRESSION AND PREDICTORS OF PROGRESSION USING A CLAIMS- AND ELECTRONIC HEALTH RECORD-INTEGRATED DATABASE

    May 1, 2019, 00:00

  • PCN235 THE ROLE OF CLINICAL EVIDENCE SUBMITTED BY MANUFACTURERS TOWARDS ACCELERATED ACCESS APPROVAL; EVIDENCE FROM SEVEN COUNTRIES

    May 1, 2019, 00:00

  • PMS9 EVALUATING THE PERFORMANCE OF THREE ELECTRONIC PATIENT-REPORTED OUTCOMES (EPRO) MEASURES IN TOTAL KNEE ARTHROPLASTY (TKA)

    May 1, 2019, 00:00

  • PCV7 EFFECTIVENESS OF A CARDIOVASCULAR RISK MANAGEMENT PROGRAM IN THE REDUCTION OF PREMATURE MORTALITY ASSOCIATED TO CARDIOVASCULAR EVENTS IN THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2019, 00:00

  • PDG68 TO EXAMINE DIFFERENCES IN OPIOID PRESCRIBING AND ADJUNCT PAIN SERVICES BY CONCENTRATION OF OPIOID PRESCRIBING PATTERNS IN VETERANS' ADMINISTRATION MEDICAL CENTERS IN THE U.S.

    May 1, 2019, 00:00

  • PNS251 CULTURAL ADAPTATION AND VALIDATION OF THE KOREAN VERSION OF IMTA PRODUCTIVITY COST QUESTIONNAIRE (IPCQ)

    May 1, 2019, 00:00

  • PCV13 RISK OF CARDIOVASCULAR OUTCOMES AND ANTIHYPERTENSIVE TRIPLE COMBINATION THERAPY AMONG PATIENTS ENROLLED IN A MEDICARE ADVANTAGE PLAN (MAP)

    May 1, 2019, 00:00

  • PNS180 UNMET NEEDS EXIST IN PAYER COMMUNICATIONS - ARE DIGITAL SOLUTIONS THE ANSWER?

    May 1, 2019, 00:00

  • Neurological Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PCN300 EVALUATION OF OVERALL SURVIVAL ASSOCIATED WITH CHANGE IN DOSING OF BORTEZOMIB, MELPHALAN, AND PREDNISONE REGIMEN IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A REAL-WORLD STUDY

    May 1, 2019, 00:00

  • Mental Health - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PMH57 ASSESSMENT OF HUMANISTIC BURDEN, A PATIENT REPORTED OUTCOMES STUDY OF MENTAL DISORDERS IN JAPAN AND CHINA

    May 1, 2019, 00:00

  • PIN58 PREVALENCE OF PARASITE INTESTINAL INFECTIONS IN A RURAL COMMUNITY OF THE CARIBBEAN NORTH OF COLOMBIA

    May 1, 2019, 00:00

  • PMS10 TREATMENT-RELATED LIVER INJURIES AMONG PATIENTS WITH SPONDYLOARTHRITIDES (SPA)

    May 1, 2019, 00:00

  • PND42 COST-EFFECTIVENESS ANALYSIS OF ERENUMAB VERSUS TOPIRAMATE FOR PATIENTS WITH CHRONIC MIGRAINES TO IDENTIFY THE COST-EFFECTIVE PRICE THRESHOLD IN GREECE

    May 1, 2019, 00:00

  • Drugs Generics - Patient-Centered Research

    May 1, 2019, 00:00

  • PMD26 MEDICAL RESOURCE UTILIZATION AND COSTS FOR INTRAOPERATIVE PERIPROSTHETIC HIP FRACTURES DURING TOTAL HIP ARTHROPLASTY IN THE MEDICARE POPULATION: A DIRECT AND PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2019, 00:00

  • NO Specific Disease - Clinical Outcomes

    May 1, 2019, 00:00

  • PMD13 ECONOMICS EVALUATION OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR LIVER CANCER: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PNS139 EVALUATION OF HUNGARIAN ONE-DAY SURGERY IN LIGHT OF DIAGNOSIS RELATED GROUPS’ VALUE

    May 1, 2019, 00:00

  • PCV83 THE BENEFITS OF DEFERRED PAYMENT IN CONGESTIVE HEART FAILURE GENE THERAPY

    May 1, 2019, 00:00

  • Neurological Disorders - Patient-Centered Research

    May 1, 2019, 00:00

  • PMS20 COMPARATIVE EFFECTIVENESS OF NOVEL VERSUS TRADITIONAL RHEUMATOID ARTHRITIS THERAPIES - A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PIN40 POST-OPERATIVE ANTIBIOTIC COST PROJECT: DISCONTINUATION OF ANTIMICROBIAL PROPHYLAXIS AFTER SURGICAL INCISION CLOSURE

    May 1, 2019, 00:00

  • PH2 DUAL-TRAJECTORIES OF OPIOID AND GABAPENTINOID USE AND RISK OF SUBSEQUENT DRUG OVERDOSE AMONG UNITED STATES MEDICARE BENEFICIARIES

    May 1, 2019, 00:00

  • PNS123 RISK ADJUSTING MEDICARE ADVANTAGE PLAN PERFORMANCE MEASURES FOR SOCIAL DETERMINANTS OF HEALTH: ARE DUAL ELIGIBILITY AND DISABILITY STATUS ENOUGH?

    May 1, 2019, 00:00

  • PIH70 EXPLORING VARIABILITY IN PATIENT-REPORTED PAIN AND TREATMENT EFFICACY IN PATIENTS WITH ENDOMETRIOSIS

    May 1, 2019, 00:00

  • Infectious Diseases - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PDB52 LITERATURE REVIEW OF ECONOMIC AND CLINICAL OUTCOMES ASSOCIATED WITH MULTIPLE DAILY INSULIN INJECTION (MDI) THERAPY FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)

    May 1, 2019, 00:00

  • PCV102 HEALTH RELATED QUALITY OF LIFE OF STROKE SURVIVORS COMPARED TO NON-STROKE INDIVIDUALS AMONG AFRICAN AMERICANS IN THE UNITED STATES: A NATIONALLY REPRESENTATIVE PROPENSITY SCORE MATCHED ANALYSIS

    May 1, 2019, 00:00

  • PNS13 DYNAMIC APPROACHES TO VISUALIZING HEOR DATA: TELLING A COMPLICATED NMA STORY, MORE SIMPLY

    May 1, 2019, 00:00

  • PDB43 SYSTEMATIC REVIEW OF THE COST EFFECTIVENESS ANALYSIS OF LIFESTYLE INTERVENTION VERSUS STANDARD CARE FOR PREVENTION OF TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PCN251 ESTIMATING QUALITY-ADJUSTED LIFE YEARS (QALYS) THROUGH QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (QTWIST) IN RCTS: AN ALTERNATIVE TO ECONOMIC MODELLING

    May 1, 2019, 00:00

  • PND54 BURDEN OF DISEASE ASSOCIATED WITH DEMENTIA-RELATED PSYCHOSIS USING A NATIONAL LONG-TERM CARE US DATABASE

    May 1, 2019, 00:00

  • PDG42 OPIOID USE FOR TREATMENT OF ACUTE PAIN AMONG CHILDREN AND ADOLESCENTS ENROLLED IN THE MISSISSIPPI MEDICAID PROGRAM

    May 1, 2019, 00:00

  • Individual's Health - Clinical Outcomes

    May 1, 2019, 00:00

  • PDB20 THE IMPACT OF ANXIETY AND DEPRESSION IN TYPE 1 DIABETES MELLITUS (T1DM) PATIENTS WHO EXPERIENCE SEVERE HYPOGLYCEMIC EPISODES (HYPOS)

    May 1, 2019, 00:00

  • PNS156 THE EFFECTIVENESS OF PERSONALISATION ON HEALTH OUTCOMES OF OLDER PEOPLE: A SYSTEMATIC REVIEW.

    May 1, 2019, 00:00

  • PNS14 BIOSIMILARS: GROWTH AND OPPORTUNITIES

    May 1, 2019, 00:00

  • Individual's Health - Patient-Centered Research

    May 1, 2019, 00:00

  • Infectious Diseases - Patient-Centered Research

    May 1, 2019, 00:00

  • Drugs Public Health

    May 1, 2019, 00:00

  • PDB47 HEALTHCARE UTILIZATION AND DIRECT MEDICAL COSTS OF HYPOGLYCEMIA IN PATIENTS WITH TYPE 2 DIABETES IN TIANJIN, CHINA

    May 1, 2019, 00:00

  • PH3 A RETROSPECTIVE DATABASE ANALYSIS OF SHORT-ACTING AND LONG-ACTING OPIOID USE IN WOMEN WITH ENDOMETRIOSIS: I-DEMOGRAPHIC CHARACTERISTICS AND PREVALENCE OF USE

    May 1, 2019, 00:00

  • PCV85 STRESS MANAGEMENT EDUCATION AND COUNSELING AMONG HYPERTENSIVE PATIENTS: AN ANALYSIS OF AMBULATORY CARE SURVEY DATA

    May 1, 2019, 00:00

  • PCN265 BREAST CANCER PATIENT PREFERENCE AND WILLINGNESS TO PAY FOR GRANULOCYTE COLONY-STIMULATING FACTORS (G-CSF)

    May 1, 2019, 00:00

  • PDB85 IMPACT OF TYPE OF INSURANCE COVERAGE ON QUALITY OF DIABETES CARE

    May 1, 2019, 00:00

  • PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT DISCONTINUATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREATMENT IN U.S. HOSPITALS: 2012-2015

    May 1, 2019, 00:00

  • PNS254 A DESIGN THINKING APPROACH TO PATIENT SUPPORT PROGRAMS

    May 1, 2019, 00:00

  • PCN316 BRCA TESTING UTILIZATION AND REIMBURSEMENT TRENDS IN THE UNITED STATES FROM 2007-2016: A DESCRIPTIVE ANALYSIS

    May 1, 2019, 00:00

  • PCN262 PREFERENCE-WEIGHTED HEALTH STATUS IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL) TREATED WITH LISOCABTAGENE MARALEUCEL (LISO-CEL; JCAR017) IN THE ONGOING, MULTICENTER, PHASE 1 TRANSCEND NHL 001 TRIAL

    May 1, 2019, 00:00

  • PCV17 ASSOCIATION BETWEEN EXPOSURE/ADHERENCE TO A CARDIOVASCULAR RISK MANAGEMENT PROGRAM AND THE INCIDENCE AND MORTALITY OF CARDIOVASCULAR EVENTS IN THE CARIBBEAN REGION OF COLOMBIA

    May 1, 2019, 00:00

  • PND58 RISK FACTORS OF EARLY-ONSET DEMENTIA AMONG PEOPLE LIVING WITH HIV/AIDS: A CLAIMS DATA ANALYSIS

    May 1, 2019, 00:00

  • PMH21 THE ECONOMIC BURDEN OF ILLNESS OF SCHIZOPHRENIA IN THE US

    May 1, 2019, 00:00

  • PDG35 COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE RIVAROXABAN PLUS ASPIRIN FOR THE PATIENTS WITH STABLE CARDIOVASCULAR DISEASE IN TAIWAN SETTING

    May 1, 2019, 00:00

  • PNS206 CAN WE IMPROVE THE ESTIMATION OF CENSORED COST DATA USING RANDOM FORESTS?

    May 1, 2019, 00:00

  • PND29 COST-EFFECTIVENESS OF MIROGABALIN FOR THE TREATMENT OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN TAIWAN

    May 1, 2019, 00:00

  • PND22 THE BURDEN OF NON-MOTOR SYMPTOMS ON HEALTHCARE RESOURCE UTILISATION AMONG PATIENTS WITH PARKINSON'S DISEASE: A NEUROLOGIST/PATIENT REAL-WORLD ASSESSMENT IN THE US

    May 1, 2019, 00:00

  • PCN273 A SYSTEMATIC LITERATURE REVIEW OF THE HEALTH-RELATED QUALITY OF LIFE BURDEN ASSOCIATED WITH NON-MUSCLE INVASIVE BLADDER CANCER AND RADICAL CYSTECTOMY

    May 1, 2019, 00:00

  • PPM8 A MACHINE LEARNING MODEL FOR CANCER BIOMARKER IDENTIFICATION IN ELECTRONIC HEALTH RECORDS

    May 1, 2019, 00:00

  • PDB100 PREDICTING HYPOPARATHYROIDISM DIAGNOSIS IN MEDICARE CLAIMS - EXPLORING THE UTILITY OF SEQUENCE ANALYSIS

    May 1, 2019, 00:00

  • PCV62 ASSESSING THE RISK FACTORS OF HEART FAILURE AMONG PATIENTS IN THE DEPARTMENT OF DEFENSE POPULATION

    May 1, 2019, 00:00

  • Mental Health - Economic Evaluation

    May 1, 2019, 00:00

  • PMD17 ESTIMATION OF US HOSPITAL COST SAVINGS ASSOCIATED WITH HYPOTENSION REDUCTION FOR MEAN ARTERIAL PRESSURE (MAP) ABOVE 65MMHG IN SEPTIC INTENSIVE CARE UNIT PATIENTS

    May 1, 2019, 00:00

  • PMU30 CHANGE IN THE PREVALENCE OF DEPRESSION AMONG PEOPLE WITH HYPERTENSION BETWEEN THE JNC 7 AND ACC/AHA 2017 GUIDELINES: US NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES), 2008-2016 COHORT

    May 1, 2019, 00:00

  • PNS82 IMPACT OF INTERNATIONAL PRICE INDEX ON PART B REIMBURSEMENT LIMITS

    May 1, 2019, 00:00

  • PNS94 CURRENT UTILIZATION AND PERCEPTIONS OF VALUE ASSESSMENT FRAMEWORKS BY PHARMACY AND THERAPEUTICS COMMITTEES IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • PDB16 TRENDS IN THE QUALITY OF DIABETES CARE IN THE UNITED STATES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES), 1999 TO 2016

    May 1, 2019, 00:00

  • PCV24 INCREMENTAL DIRECT HEALTHCARE EXPENDITURES OF VALVULAR HEART DISEASE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PNS218 ASSESSING THE GENERALIZABILITY OF CLINICAL TRIALS WITHOUT INDIVIDUAL-LEVEL TRIAL DATA

    May 1, 2019, 00:00

  • PCV86 THE RELATIONSHIP BETWEEN SIGNATURE TIME AND FUNCTIONAL HEALTH LITERACY IN AN UNDERSERVED URBAN POPULATION

    May 1, 2019, 00:00

  • PIH55 NATIONAL PATTERNS OF EMERGENCY DEPARTMENT USE FOR WOMEN WITH ENDOMETRIOSIS, 2006-2015

    May 1, 2019, 00:00

  • PNS189 A CAPACITY ASSESSMENT FOR A CLINICAL PHARMACY SERVICE OF A PUBLIC-SCHOOL HOSPITAL: A DISCRETE-EVENT SIMULATION CASE STUDY

    May 1, 2019, 00:00

  • PCV31 COMPARISON OF COST-EFFECTIVENESS BETWEEN SACUBITRIL/VALSARTAN AND VALSARTAN WITH ENALAPRIL IN HEART FAILURE

    May 1, 2019, 00:00

  • PCV44 COST-EFFECTIVENESS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: ANALYSIS OF REAL WORLD DATA

    May 1, 2019, 00:00

  • PNS258 THE INCLUSION OF THE UTILITY VALUES FOR CARERS AND FAMILY MEMBERS IN HTAS: A CASE STUDY OF RECENT NICE APPRAISALS IN THE UK

    May 1, 2019, 00:00

  • PCN269 DETERMINATION OF HEALTH-RELATED QUALITY OF LIFE BY USING EQ-5D 3L IN CANCER PATIENTS IN SWAT, KHYBER PAKHTUNKHWA PAKISTAN

    May 1, 2019, 00:00

  • Real-World Evidence, Causal Inference, and Machine Learning

    May 1, 2019, 00:00

  • PCV53 THERAPEUTIC INTENSITY ALGORITHM IS ASSOCIATED WITH ANNUAL EXPENDITURES IN MEDICALLY MANAGED INCIDENT HEART FAILURE PATIENTS WITH AND WITHOUT MITRAL REGURGITATION

    May 1, 2019, 00:00

  • NO Specific Disease - Real World Data Information Systems

    May 1, 2019, 00:00

  • PCV72 HEALTH BEHAVIORS AMONG MYOCARDIAL INFARCTION SURVIVORS IN THE UNITED STATES: A PROPENSITY SCORE MATCHED STUDY

    May 1, 2019, 00:00

  • PNS249 WHAT ARE THE PRIORITY PATIENT ENGAGEMENT ACTIVITIES IN MEDICINES DEVELOPMENT? RESULTS OF A GLOBAL MULTI-STAKEHOLDER CONSULTATION

    May 1, 2019, 00:00

  • PND12 CLINICAL EFFICACY OF VALBENAZINE AND DEUTETRABENAZINE FOR THE TREATMENT OF TARDIVE DYSKINESIA: INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2019, 00:00

  • PIT6 COST-EFFECTIVENESS OF PHENYTOIN VERSUS LEVETIRACETAM FOR EARLY SEIZURE PHARMACOPROPHYLAXIS AFTER TRAUMATIC BRAIN INJURY: TRIAL-BASED ANALYSIS IN A PATIENT PERSPECTIVE

    May 1, 2019, 00:00

  • PNS246 EXPLORING THE PERFORMANCE OF USING DISCRETE CHOICE EXPERIMENTS FOR ELICITING HEALTH STATE UTILITIES IN CHINA: EVIDENCE FROM SF-6D V2

    May 1, 2019, 00:00

  • PDG52 A COMPARATIVE ANALYSIS ON THE RISKS OF USING OTC PRODUCTS COMPARED TO PRESCRIPTION DRUGS

    May 1, 2019, 00:00

  • PNS86 INCREASE OF ONE-DAY SURGERY CASE NUMBERS IN LIGHT OF HEALTH CARE INSTITUTIONS – HUNGARIAN EXPERIENCES BETWEEN 2008-2017

    May 1, 2019, 00:00

  • PMH64 TREATMENT EXPERIENCES OF PATIENTS WITH BIPOLAR I DISORDER: A QUALITATIVE FOCUS GROUP STUDY

    May 1, 2019, 00:00

  • PNS198 DEVELOPMENT OF EARLY DECISION ANALYTICS (DA) PLATFORM TO SUPPORT RESEARCH AND DEVELOPMENT MILESTONES WITH ANTICIPATED REAL-WORLD VALUE

    May 1, 2019, 00:00

  • PGI10 COST-EFFECTIVENESS ANALYSIS OF RADIO-FREQUENCY ABLATION IN PATIENTS WITH BARRETT’S ESOPHAGUS AND HIGH GRADE DYSPLASIA IN ITALY

    May 1, 2019, 00:00

  • PCN295 PATIENT-CENTERED OUTCOMES IN ARIEL3, A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH RECURRENT OVARIAN CARCINOMA

    May 1, 2019, 00:00

  • PDB102 MODELLING PROGRESSION OF RISK FACTORS IN PATIENTS WITH TYPE 1 DIABETES: TOWARDS THE MOST APPROPRIATE FUNCTIONAL FORMS FOR A SIMULATION MODEL OF LONG-TERM HEALTH OUTCOMES

    May 1, 2019, 00:00

  • Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling

    May 1, 2019, 00:00

  • PCV75 MULTI-CENTER STUDY ON THE IMPACT OF CYTOCHROME P450 3A4 AND P-GLYCOPROTEIN INTERACTING MEDICATIONS ON BLEEDING AND THROMBOEMBOLISM RISK IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS MANAGED ON RIVAROXABAN THERAPY

    May 1, 2019, 00:00

  • PDB97 IMPACT TO DIABETES QUALITY PERFORMANCE MEASURES IN AN OLDER ADULT POPULATION WHEN USING A 24-HOUR WEARABLE INSULIN DELIVERY DEVICE FOR BASAL-BOLUS INSULIN THERAPY

    May 1, 2019, 00:00

  • PNS209 USING META-ANALYSIS TO EVALUATE HETEROGENEITY ACROSS A NETWORK OF HEALTH DATA PROVIDERS

    May 1, 2019, 00:00

  • PMS33 EPIDEMIOLOGY AND ECONOMIC BURDEN OF TOTAL HIP ARTHROPLASTY IN JAPAN

    May 1, 2019, 00:00

  • PCV94 PRESCRIBING PATTERNS FOR PATIENTS WITH HEART FAILURE AT DISCHARGE IN A TERTIARY HOSPITAL, IN RIYADH

    May 1, 2019, 00:00

  • PNS208 A TARGETED LITERATURE REVIEW COMPARING MACHINE LEARNING ALGORITHMS TO STANDARD REGRESSION MODELS IN REAL WORLD EVIDENCE

    May 1, 2019, 00:00

  • PNS240 A COMPARISON OF METHODS FOR ANCHORING DCE-DERIVED LATENT UTILITIES ONTO THE QALY SCALE: EVIDENCE FROM SF-6D V2

    May 1, 2019, 00:00

  • PNS65 DESCRIPTIVE EPIDEMIOLOGY OF SMOKING STATUS IN A REAL WORLD SAMPLE OF ADULTS IN THE UNITED STATES: 2010 - 2017

    May 1, 2019, 00:00

  • PNS54 SYSTEMATIC REVIEW AND BENCHMARKING OF US BUDGET IMPACT ANALYSES

    May 1, 2019, 00:00

  • PDG66 METFORMIN DOSAGE PATTERNS IN TYPE 2 DIABETES PATIENTS IN A REAL-WORLD HEALTHCARE SETTING IN THE UNITED STATES

    May 1, 2019, 00:00

  • PDB75 EVENT RATE OF HYPOGLYCEMIA AND PREVALENCE OF COMORBIDITIES IN PATIENTS WITH TYPE 2 DIABETES IN TIANJIN, CHINA

    May 1, 2019, 00:00

  • PMH52 ARE PHYSICIANS COMPLYING WITH AAP-2011 TREATMENT GUIDELINES FOR ADHD? A COMPARATIVE ANALYSIS OF SPECIALIST VS. NONSPECIALIST PRESCRIBING AND USE OF PSYCHOTHERAPY IN CHILDREN

    May 1, 2019, 00:00

  • PMU76 EVIDENCE OF BETTER HTA OUTCOMES FOR COMBINATION PRODUCTS INVOLVING ONLY A SINGLE COMPANY IN EUROPE

    May 1, 2019, 00:00

  • PNS200 METHODOLOGICAL VARIATIONS AMONG HEALTH STATE VALUATION STUDIES USING EQ-5D-5L: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PGI21 OPTIMAL PATIENT SELECTION AND REFERRAL CARE PATHWAYS FOR ANTI-REFLUX SURGICAL PROCEDURES

    May 1, 2019, 00:00

  • PIT9 EXAMINING THE REAL-WORLD HEALTHCARE COSTS OF TREATING CHRONIC WOUNDS

    May 1, 2019, 00:00

  • PNS173 EVALUATION OF THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) PUBLIC ENGAGEMENT PROCESS: STAKEHOLDER COMMENT ANALYSIS

    May 1, 2019, 00:00

  • PCV30 ESTIMATING HEALTH-STATE UTILITY IN PATIENTS WITH HEART FAILURE: MAPPING THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE TO SF-6D UTILITY SCORES

    May 1, 2019, 00:00

  • PDG69 NATIONWIDE TRENDS IN PRESCRIPTION OPIOID USE AMONG ADULTS: A PRE-PUBLIC HEALTH EMERGENCY PERSPECTIVE ON THE OPIOID CRISIS

    May 1, 2019, 00:00

  • PIH14 IMPROVING DEMENTIA ECONOMICS THROUGH EARLIER COST-EFECTIVE ASSESSMENT

    May 1, 2019, 00:00

  • PNS176 ECONOMIC EVALUATION OF MEDICAL DEVICES: ARE THERE LESSONS TO BE LEARNT FROM EUROPE

    May 1, 2019, 00:00

  • PMU34 BETA-BLOCKERS AND COGNITIVE IMPAIRMENT AMONG ADULTS WITH HYPERTENSION OR CARDIOVASCULAR DISEASES IN THE UNITES STATES

    May 1, 2019, 00:00

  • PDB30 COMPARABILITY OF RESULTS USING TWO ALTERNATIVE VERSIONS OF THE IQVIA CORE DIABETES MODEL

    May 1, 2019, 00:00

  • PDG83 ATTITUDES AND INTENTION OF PHARMD STUDENTS TO USE STIMULANTS FOR ENHANCING ACADEMIC PERFORMANCE

    May 1, 2019, 00:00

  • NO Specific Disease - Medical Technologies

    May 1, 2019, 00:00

  • PDG77 THE EMERGENCE OF THERAPEUTIC RADIOPHARMACEUTICALS. DO THE EXTRA COSTS OUTWEIGH THE GAINS?

    May 1, 2019, 00:00

  • PIN66 VACCINE PREGNANCY REGISTRIES: METHODS AND IMPACT ON FINDINGS

    May 1, 2019, 00:00

  • PDG43 SAFETY EVALUATION OF ZOLEDRONIC ACID AND DENOSUMAB USING FDA ADVERSE EVENT REPORTING SYSTEM (FAERS) DATABASE 2012-2018

    May 1, 2019, 00:00

  • PDB72 RESOURCES USE AND ECONOMIC IMPACT OF PATIENTS WITH GOUT: REAL WORD EVIDENCE

    May 1, 2019, 00:00

  • PNS168 CHALLENGES IN THE DESIGN AND IMPLEMENTATION OF COVERAGE WITH DEVELOPMENT SCHEMES FOR MEDICAL DEVICES

    May 1, 2019, 00:00

  • Mental Health - Clinical Outcomes

    May 1, 2019, 00:00

  • PNS20 A CONCEPTUAL PAPER ON DEVELOPING AND VALIDATING A NOVEL INDEX; DOCTOR'S SAFETY INDEX (DSI) THAT CAN AID HOSPITAL HEALTH POLICY TO TACKLE THE GROWING WORKPLACE VIOLENCE AGAINST DOCTORS.

    May 1, 2019, 00:00

  • PCN307 IMPACT OF EHR TECHNOLOGY UPDATES ON PATIENTS' ACCESS TO ONCOLOGY DRUGS

    May 1, 2019, 00:00

  • PCN283 HEALTH-RELATED QUALITY OF LIFE ASSOCIATED WITH BARRETTS ESOPHAGUS AND CANCER

    May 1, 2019, 00:00

  • PIN29 ESTIMATION OF THE CLINICAL OUTCOMES AND COST-EFFECTIVENESS OF DOLUTEGRAVIR/LAMIVUDINE (DTG/3TC) AS A TEST AND TREAT (TT) ANTIRETROVIRAL (ARV) REGIMEN FOR TREATMENT-NAIVE PATIENTS WITH HIV-1 INFECTION IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCV92 IMPROVING MEMBERS HYPERTENSION AT BLUE CROSS BLUE SHIELD OF LOUISIANA: THE EFFECTIVENESS OF OCHSNER'S DIGITAL MEDICINE HYPERTENSION (DMH) PROGRAM

    May 1, 2019, 00:00

  • PCN256 CONTROL OF LEAD TIME BIAS IN HEALTH TECHNOLOGY ASSESSMENT: METHOD AND EXAMPLES

    May 1, 2019, 00:00

  • PMU39 APPROACHES TO SAFETY REPORTING IN OBSERVATIONAL STUDIES

    May 1, 2019, 00:00

  • PDG64 OPTIMISING ANTIBIOTIC PRESCRIBING IN DEVELOPING COUNTRIES

    May 1, 2019, 00:00

  • PNS78 DIFFERENCES BETWEEN ENROLLEES OF INDIVIDUAL VERSUS SMALL GROUP OFF-EXCHANGE HEALTH PLANS UNDER THE AFFORDABLE CARE ACT

    May 1, 2019, 00:00

  • PNS63 MODELING REDUCTIONS IN ABSOLUTE CANCER MORTALITY FROM DIAGNOSING CANCERS BEFORE METASTASIS, 2006-2015

    May 1, 2019, 00:00

  • PMU31 ANALYSIS OF RISK FACTORS ASSOCIATED WITH INFECTION AND MORTALITY AMONG HOSPITALIZED LUNG CANCER PATIENTS

    May 1, 2019, 00:00

  • PMH23 BUDGET IMPACT ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN247 PROGRESSION-FREE SURVIVAL (PFS) WITH DARATUMUMAB- BORTEZOMIB-MELPHALAN-PREDNISONE (D-VMP) COMBINATION THERAPY AND ALTERNATIVE TREATMENTS FOR PATIENTS WITH NEWLY-DIAGNOSED MULTIPLE MYELOMA (MM) INELIGIBLE FOR STEM CELL TRANSPLANTATION ...

    May 1, 2019, 00:00

  • PCN234 DEVELOPMENT AND VALIDATION STUDY OF ARTIFICIAL INTELLIGENCE SUPPORTING SYSTEMATIC LITERATURE REVIEW FOR CONDUCTING COST-EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • “Time Traveling Is Just Too Dangerous” but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier

    May 1, 2019, 00:00

  • RARE Orphan Diseases - Clinical Outcomes

    May 1, 2019, 00:00

  • PNS166 CROSS-COUNTRY ICER EVOLUTION: WHAT DOES IT NOW MEAN TO BE COST-EFFECTIVE?

    May 1, 2019, 00:00

  • PCV26 A COMPARISON OF THE COSTS OF ATRIAL FIBRILLATION ABLATION USING RADIOFREQUENCY CONTACT FORCE AND CRYOBALLOON TECHNOLOGIES IN THE UNITED STATES: AN ANALYSIS OF PROPENSITY SCORE MATCHED POPULATIONS

    May 1, 2019, 00:00

  • PDB110 PATIENT ACTIVATION AND ANTIDIABETIC MEDICATION ADHERENCE AMONG MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES

    May 1, 2019, 00:00

  • PDG56 THE EFFECTIVENESS OF ENROLLMENT TYPE IN PRESCRIPTION DRUG MONITORING PROGRAMS: A RETROSPECTIVE STUDY

    May 1, 2019, 00:00

  • PDG12 EFFECTS OF MEDICAID EXPANSION ON ADHERENCE TO ORAL HYPOGLYCEMIC MEDICATIONS IN LOW-INCOME POPULATIONS

    May 1, 2019, 00:00

  • Multiple Diseases - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PND86 REPLICATION OF A US CLAIMS BASED ALGORITHM TO IDENTIFY MULTIPLE SCLEROSIS DISEASE SEVERITY BASED ON HEALTHCARE COSTS

    May 1, 2019, 00:00

  • PCV22 COST-EFFECTIVENESS ANALYSIS OF OLMESARTAN/AMLODIPINE FIX-DOSE COMBINATION FOR HYPERTENSIVE PATIENTS IN CHINA

    May 1, 2019, 00:00

  • PCN246 A SYSTEMATIC APPROACH FOR QUANTIFYING HETEROGENEITY WITHIN CLINICAL TRIAL POPULATIONS

    May 1, 2019, 00:00

  • PCV104 PSYCHOMETRIC VALIDATION OF THE ‘GOOD DAY BAD DAY’ ITEM IN A NEUROGENIC ORTHOSTATIC HYPOTENSION (NOH) POPULATION

    May 1, 2019, 00:00

  • PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

    May 1, 2019, 00:00

  • PNS26 JAN AUSHADI SCHEME: AN INITIATIVE IN MAKING QUALITY GENERIC MEDICINES AT AFFORDABLE PRICES

    May 1, 2019, 00:00

  • PNS224 AN ADMINISTRATIVE HEALTH DATA DRIVEN SCORE FOR A HEALTH INSURANCE COMPANY: A NEW METHODOLOGICAL APPROACH

    May 1, 2019, 00:00

  • PIH63 THE UNDERSTANDING OF BLOOD CLOTTING DISEASES IN PREGNANT WOMEN AT AN INCREASED RISK

    May 1, 2019, 00:00

  • PCN239 COMPARISON OF RESOURCE UTILIZATION AND POTENTIAL COST SAVINGS FOLLOWING SCREENING WITH DIGITAL BREAST TOMOSYNTHESIS COMPARED WITH DIGITAL MAMMOGRAPHY

    May 1, 2019, 00:00

  • PMD8 COST-EFFECTIVENESS ANALYSIS OF TEGADERM CHLORHEXIDINE GLUCONATE(CHG) DRESSING VERSUS STANDARD DRESSING IN PATIENTS WITH CENTRAL VENOUS CATHETER IN CHINESE INTENSIVE CARE UNITS

    May 1, 2019, 00:00

  • PNS256 HOW TO RESOLVE PROBLEMS EXPERIENCED WITH REGULATORY APPROVAL, PRICING AND LAUNCH PLAN OF PHARMACEUTICAL PRODUCTS WHEN PATIENTS ARE INVOLVED

    May 1, 2019, 00:00

  • PIH2 DEVELOPMENT AND VALIDATION OF A PATIENT CENTERED OUTCOME MEASURE FOR USE IN DEMENTIA DRUG TRIALS

    May 1, 2019, 00:00

  • PMH4 AN INDIRECT TREATMENT COMPARISON OF BREXPIPRAZOLE VERSUS LURASIDONE IN PATIENTS UNDERGOING ACUTE AND MAINTENANCE PHASE TREATMENT FOR SCHIZOPHRENIA

    May 1, 2019, 00:00

  • NO Specific Disease - Economic Evaluation

    May 1, 2019, 00:00

  • PNS6 THE USE OF VARIABLE WILLINGNESS-TO-PAY THRESHOLDS IN HTA DECISION-MAKING TO REFLECT SOCIETAL VALUES FOR HEALTHCARE PROVISION

    May 1, 2019, 00:00

  • PNS214 MEDICATION INVENTORY AND MANAGEMENT EFFICIENCIES MODELLED WITHIN A HEALTH-SYSTEM'S AFFILIATED OUTPATIENT CLINICS

    May 1, 2019, 00:00

  • PCN286 COMPARING EQ-5D-3L AND EQ-5D-5L PSYCHOMETRIC PROPERTIES OF COMMON CANCERS IN CHINA: A CROSS-SECTIONAL STUDY

    May 1, 2019, 00:00

  • Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery

    May 1, 2019, 00:00

  • PNS43 IDENTIFYING AND ASSESSING THE FEASIBILITY OF PROPOSED ALTERNATIVE APPROACHES TO QALY ESTIMATION WITHIN COST-EFFECTIVENESS MODELS USING A SYSTEMATIC LITERATURE REVIEW: AN UPDATED ANALYSIS

    May 1, 2019, 00:00

  • PDB124 REAL WORLD CHART REVIEW EXAMINATION OF LORCASERIN TREATMENT IN WEIGHT MANAGEMENT

    May 1, 2019, 00:00

  • PDB89 PREDICTIVE MODEL FOR BEHAVIOR CHANGE IN A MODIFIED TELEHEALTH DIABETES PREVENTION PROGRAM

    May 1, 2019, 00:00

  • PIN71 VACCINATION AND POTENTIAL MISSED OPPORTUNITIES AMONG ADULTS IN THE UNITED STATES DURING THE AFFORDABLE CARE ACT ERA

    May 1, 2019, 00:00

  • PIH9 UNMET NEED ASSOCIATED WITH AVAILABLE THERAPEUTIC OPTIONS FOR MANAGEMENT OF DYSPAREUNIA RELATED TO GENITOURINARY SYNDROME OF MENOPAUSE: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PDB5 A SERIES OF BIOSTATISTICAL METHODOLOGICAL ANALYSIS ABOUT THE RELATION AMONG CLINICAL LABORATORY TESTS’ RESULTS

    May 1, 2019, 00:00

  • PNS247 PATIENT BURDEN TO FAMILY: AN EXAMINATION OF IMPORTANCE AND WORDING

    May 1, 2019, 00:00

  • PCN258 IMPROVING THE ACCURACY OF MEASURING DURATION OF THERAPY BY IDENTIFYING PATIENTS WHO REMAIN ON-TREATMENT IN A REAL-WORLD DATABASE

    May 1, 2019, 00:00

  • PDG34 META-ANALYSIS AND COST-EFFECTIVENESS ANALYSIS OF INSULIN GLARGINE 100 U/ML VERSUS INSULIN DEGLUDEC FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS

    May 1, 2019, 00:00

  • PIN83 ADULT VACCINATION IN BRAZIL: A NATIONAL CROSS-SECTIONAL SURVEY ON PHYSICIANS PRESCRIPTION HABITS

    May 1, 2019, 00:00

  • PND92 EXTENT AND FACTORS ASSOCIATED WITH ADHERENCE TO APPROPRIATE ANTIDEPRESSANT TREATMENT DURING ACUTE AND CONTINUATION PHASE DEPRESSION TREATMENT AMONG OLDER ADULTS WITH DEMENTIA AND MAJOR DEPRESSIVE DISORDER

    May 1, 2019, 00:00

  • Multiple Diseases - Real World Data Information Systems

    May 1, 2019, 00:00

  • PMS34 IMPACT OF OCCUPATIONAL PSYCHOSOCIAL RISK FACTORS ON FREQUENT, SEVERE LOW BACK PAIN IN THE US WORKING POPULATION

    May 1, 2019, 00:00

  • PCV113 DIFFERENCE-IN-DIFFERENCES ANALYSIS OF THE IMPACT OF ORAL ANTICOAGULANT PRESCRIBING ON INCIDENCE OF ATRIAL-FIBRILLATION-RELATED STROKE

    May 1, 2019, 00:00

  • PMD5 ASSOCIATION BETWEEN BUPRENORPHINE RETENTION/ADHERENCE AND HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS: A LITERATURE REVIEW

    May 1, 2019, 00:00

  • PND68 COST-EFFECTIVENESS OF OCRELIZUMAB COMPARED TO FINGOLIMOD OR DMF IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CZECH REPUBLIC

    May 1, 2019, 00:00

  • PDB19 THE IMPACT OF ANTIDEPRESSANT TREATMENT DOSE ON CLINICAL OUTCOMES OF TYPE 2 DIABETES MELLITUS IN PRIMARY CARE PATIENTS IN WESTERN PENNSYLVANIA

    May 1, 2019, 00:00

  • PDB53 IS HIGHER-PRICED INSULIN ASSOCIATED WITH BETTER ECONOMIC AND HEALTH OUTCOMES? A STUDY FROM A VALUE-BASED PAYMENT PERSPECTIVE

    May 1, 2019, 00:00

  • PMH48 DISPARITIES IN COGNITIVE IMPAIRMENT WITH ANTICHOLINERGIC DRUG USE: ANALYSIS OF THE REASONS FOR GEOGRAPHIC AND RACIAL DIFFERENCES IN STROKE (REGARDS) STUDY

    May 1, 2019, 00:00

  • PIN98 STUDY ON PREFERENCE OF VACCINATION SCHEME SELECTION FOR CERVICAL CANCER

    May 1, 2019, 00:00

  • PMU55 CHARACTERIZING CHRONIC CONDITION PATIENTS IN THE MEDICAID COVERAGE GAP USING MEDICAL EXPENDITURE PANEL SURVEY (MEPS) DATA

    May 1, 2019, 00:00

  • PND40 BUDGET IMPACT ANALYSIS OF GALCANEZUMAB-GNLM FOR THE PREVENTIVE TREATMENT OF PATIENTS WITH CHRONIC AND EPISODIC MIGRAINE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PDB62 INCIDENCE AND COST OF DIABETES RELATED EVENTS IN AN ADULT TYPE 1 DIABETES POPULATION FROM A U.S. PAYOR PERSPECTIVE

    May 1, 2019, 00:00

  • PDB25 THE EFFECT OF MEDICATION NON-ADHERENCE ON HOSPITALIZATION COSTS AMONG MEDICARE ENROLLEES WITH DRUG COVERAGE THROUGH A PHARMACY ASSISTANCE PROGRAM

    May 1, 2019, 00:00

  • Medical Devices - Medical Technologies

    May 1, 2019, 00:00

  • PDB69 EFFECTIVENESS AND ADHERENCE OF LEVOTHYROXINE THERAPY

    May 1, 2019, 00:00

  • PNS213 A NEW TOOL TO IMPROVE NETWORK META-ANALYSES OF SURVIVAL DATA IN HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2019, 00:00

  • PMD9 CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICE COMPARED TO USUAL CARE FOR SEVERE OBSTRUCTIVE SLEEP APNEA: A COST-EFFECTIVENESS ANALYSIS

    May 1, 2019, 00:00

  • PMU49 CHANGES IN ANALGESIC PRESCRIBING AMONG TEXAS ADVANCED PRACTICE PROVIDERS AFTER RESCHEDULING OF HYDROCODONE COMBINATION PRODUCTS

    May 1, 2019, 00:00

  • PNS62 A DESCRIPTIVE STUDY OF POTENTIALLY AVOIDABLE HOSPITALIZATIONS AMONG DISABLED PATIENTS WITH DEPRESSION OR SLEEP DISORDERS

    May 1, 2019, 00:00

  • PCN263 PROGNOSTIC VALUE OF HEALTH-RELATED QUALITY OF LIFE ON OVERALL SURVIVAL IN OLDER AMERICANS WITH KIDNEY CANCER: A POPULATION-BASED COHORT STUDY

    May 1, 2019, 00:00

  • PND79 SHARED DECISION MAKING AND USE OF DECISION AIDS IN MULTIPLE SCLEROSIS

    May 1, 2019, 00:00

  • PNS50 MODELING THE ECONOMIC VALUE OF MEDICATION SYNCHRONIZATION AMONG COMMERCIAL AND MEDICAID POPULATIONS

    May 1, 2019, 00:00

  • PCV71 CLINICAL AND ECONOMIC PROFILE OF PATIENTS WITH ACUTE AND CHRONIC HEART FAILURE IN USUAL CLINICAL PRACTICE

    May 1, 2019, 00:00

  • PDB54 TRENDS IN PRICES OF INSULIN MARKETED IN THE US

    May 1, 2019, 00:00

  • Multiple Diseases - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PNS111 SURVEY RESULTS OF CONTEMPORARY U.S. HEALTH PLAN POLICIES: NEW CHALLENGES, DIGITAL TECHNOLOGIES, VALUE-BASED CONTRACTING, AND COMPARATIVE EFFECTIVENESS RESEARCH

    May 1, 2019, 00:00

  • PIN64 COMPLETE ADHERENCE TO ANTIRETROVIRAL THERAPY AMONG HIV-INFECTED ADULTS RECEIVING MEDICAL CARE: INFLUENCE OF DURATION SINCE HIV DIAGNOSIS

    May 1, 2019, 00:00

  • PCV43 ECONOMIC VALUATION OF INFORMAL CARE PROVIDED TO PEOPLE AFTER A MYOCARDIAL INFARCTION IN FRANCE

    May 1, 2019, 00:00

  • PMU90 FRAMEWORK SYNTHESIS OF QUALITATIVE AND QUANTITATIVE EVIDENCE TO EXPLORE THE DIFFERENTIAL DIAGNOSIS OF DIARRHEA IN NEUROENDOCRINE TUMOR PATIENTS

    May 1, 2019, 00:00

  • NO Specific Disease - Methodological Statistical Research

    May 1, 2019, 00:00

  • PMS51 THE EFFECT OF WORK ABSENCES ON HEALTH SERVICES UTILIZATION AND COSTS AMONG EMPLOYED INDIVIDUALS WITH RHEUMATOID ARTHRITIS

    May 1, 2019, 00:00

  • Caring for Carers: Positive and Normative Challenges for Future Research on Carer Spillover Effects in Economic Evaluation

    May 1, 2019, 00:00

  • PCV27 EXPLORING CHANGES IN UTILIZATION AND EXPENDITURES FOR LIPID-LOWERING AGENTS BETWEEN 2011 AND 2015

    May 1, 2019, 00:00

  • PIN55 EPIDEMIOLOGY OF HPV-RELATED HIGH-GRADE CERVICAL LESIONS IN MID-ADULT WOMEN IN EUROPE

    May 1, 2019, 00:00

  • PMH14 COST EFFICIENCY OF ESKETAMINE NASAL SPRAY VERSUS STANDARD OF CARE FOR TREATMENT RESISTANT DEPRESSION

    May 1, 2019, 00:00

  • PNS232 ARE VIDEOS OR TEXT BETTER FOR DESCRIBING ATTRIBUTES IN STATED-PREFERENCE SURVEYS? SOME EXPERTS WILL BE SURPRISED

    May 1, 2019, 00:00

  • PCN266 PATIENT-REPORTED OUTCOMES IN LABELING FOR NOVEL ONCOLOGY AGENTS

    May 1, 2019, 00:00

  • PCV32 COMPARISON OF MAJOR ADVERSE CORONARY EVENTS AND COSTS OF CARE AMONG AMI PATIENTS RECEIVING STENTS, BY MULTI VESSEL DISEASE STATUS

    May 1, 2019, 00:00

  • PMH15 COST-EFFECTIVENESS OF THE MANAGING AGITATION AND RAISING QUALITY OF LIFE IN DEMENTIA (MARQUE) INTERVENTION FOR AGITATION SYMPTOMS IN PEOPLE WITH DEMENTIA IN CARE HOMES

    May 1, 2019, 00:00

  • PDB42 THE IMPACT OF MEDICATION ADHERENCE ON HEALTHCARE UTILIZATION AMONG ELDERLY PATIENTS WHO RECEIVED PRESCRIPTION ASSISTANCE THROUGH A STATE FUNDED PROGRAM

    May 1, 2019, 00:00

  • PDB3 THE ASSOCIATION BETWEEN POST-THYROIDECTOMY SERUM TRIIODOTHYRONINE-TO-THYROXINE (T3/T4) RATIO AND INCIDENCE OF METABOLIC SYNDROME CONDITIONS

    May 1, 2019, 00:00

  • PDB13 COST ANALYSIS AND THE INFLUENCE OF ADA 2011 CRITERIA ON THE PERINATAL OUTCOMES OF WOMEN WITH GESTATIONAL DIABETES MELLITUS IN CHINA

    May 1, 2019, 00:00

  • PNS210 REVIEW OF CANADIAN VERSUS OTHER GUIDELINES FOR CONDUCTING BUDGET IMPACT ANALYSIS: DO CANADIAN GUIDELINES DIFFER AND WHY?

    May 1, 2019, 00:00

  • PMS39 WORSTENING TRENDS IN OSTEOPOROSIS MANAGEMENT IN THE MEDICARE POPULATION: 2010-2014

    May 1, 2019, 00:00

  • PIN26 COST-MINIMIZATION ANALYSIS OF PAN-GENOTYPIC TREATMENT REGIMENS FOR CHRONIC HEPATITIS C

    May 1, 2019, 00:00

  • PMH51 COMORBID CONDITIONS AND MEDICATIONS IN POST TRAUMATIC STRESS DISORDER PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PMU21 A COMPARATIVE EFFECTIVENESS STUDY OF PHARMACY CARVE IN/OUT PROGRAMS: A BCBSLA PERSPECTIVE

    May 1, 2019, 00:00

  • PNS32 EQUIVALENCE TESTING: RECOMMENDATIONS FOR STANDARDIZED IMPLEMENTATION AND ANALYSIS BEST PRACTICES

    May 1, 2019, 00:00

  • PMH42 OPIOID MEDICATION UTILIZATION AND SPENDING IN MEDICARE PART D PROGRAM

    May 1, 2019, 00:00

  • PNS68 DETERMINATION OF HEALTH RELATED QUALITY OF LIFE BY USING EQ-5D 3L IN GENERAL POPULATION OF PUNJAB, PAKISTAN

    May 1, 2019, 00:00

  • PIN39 COST-EFFECTIVENESS OF PNEUMOCOCCAL VACCINATION STRATEGIES IN OLDER ADULTS OF HONG KONG

    May 1, 2019, 00:00

  • PCV95 COMPLICATIONS AND MEDICATION PATTERNS IN PREECLAMPSIA PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PCN250 SYSTEMATIC REVIEW OF VALIDATION STUDIES TO IDENTIFY LIVER, LUNG, BRAIN AND BONE METASTASES IN ADMINISTRATIVE CLAIMS DATA

    May 1, 2019, 00:00

  • PIN28 COST-EFFECTIVENESS OF QUADRIVALENT (6,11,16,18) HPV VACCINATION IN 9 TO 10 YEARS OLD FEMALES AT DIFFERENT COVERAGE RATES IN COLOMBIA

    May 1, 2019, 00:00

  • PCN254 AN INDIRECT COMPARISON OF ELOTUZUMAB, CARFILZOMIB, AND DARATUMUMAB WHEN GIVEN IN COMBINATION WITH POMALIDOMIDE AND DEXAMETHASONE FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA

    May 1, 2019, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    May 1, 2019, 00:00

  • PDB40 BUDGET IMPACT SAVINGS OF LIRAGLUTIDE 1,2MG VERSUS INSULIN IN ALGERIAN T2D PATIENTS INSUFFICIENTLY CONTROLLED WITH ORAL MEDICATIONS

    May 1, 2019, 00:00

  • Health Technology Assessment Challenges in Oncology: 20 Years of Value in Health

    May 1, 2019, 00:00

  • PND57 THE SOCIETAL BURDEN OF PRODROMAL ALZHEIMER’S DISEASE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN248 ESTIMATING THE UNBIASED OS-BENEFIT FOR APALUTAMIDE (APA) VERSUS ANDROGEN DEPRIVATION THERAPY (ADT) IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) FROM SPARTAN, ADJUSTING FOR SUBSEQUENT THERAPY USING RAN ...

    May 1, 2019, 00:00

  • PMS38 TREATMENT UTILIZATION OF COMMERCIALLY INSURED PATIENTS UNDER 65 YEARS OF AGE DIAGNOSED WITH LATERAL EPICONDYLITIS

    May 1, 2019, 00:00

  • PND87 CHARACTERISTICS OF MIGRAINE PATIENTS WITH MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORES IN REAL-WORLD CLINICAL PRACTICE

    May 1, 2019, 00:00

  • PNS252 DEVELOPMENT AND VALIDATION OF HEALTH-RELATED QUALITY OF LIFE INSTRUMENT WITH 8 ITEMS FOR GENERAL POPULATION

    May 1, 2019, 00:00

  • PMH55 SLEEP HABITS AND SLEEP QUALITY OF FOREIGN STUDENTS IN HUNGARY

    May 1, 2019, 00:00

  • PRO3 SUCCESSOR STUDY: TREATMENT AND HEALTH CARE RESOURCE UTILIZATION BY SICKLE CELL PATIENTS WHO PARTICIPATED IN THE SUSTAIN STUDY IN THE UNITED STATES

    May 1, 2019, 00:00

  • PMU23 OXYCODONE FOR CANCER PAIN TITRATION: A PHARMACOECONOMIC EVALUATION

    May 1, 2019, 00:00

  • PMU46 TRIAL SEPARATION - IS THERE A TRUE GENDER DISPARITY IN CLINICAL TRIALS?

    May 1, 2019, 00:00

  • PDG23 BUDGET IMPACT OF USING CYCLOSPORINE OPHTHALMIC SOLUTION 0.09% FOR THE TREATMENT OF DRY EYE DISEASE

    May 1, 2019, 00:00

  • PDB37 COST EFFECTIVENESS OF SODIUM-GLUCOSE COTRANSPORTER-2 (SGLT2) INHIBITORS, GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONISTS, DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Health Policy Regulatory

    May 1, 2019, 00:00

  • PND36 LONGITUDINAL COMPARISON IN EMPLOYMENT BETWEEN MULTIPLE SCLEROSIS PATIENTS VERSUS CONTROLS

    May 1, 2019, 00:00

  • PCV114 PREDICTION OF BLEEDING RISK OF NON-VALVULAR ATRIAL FIBRILLATION PATIENT TREATED WITH FACTOR XA INHIBITORS USING OPTUM ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PNS110 CONSOLIDATED DRUG PURCHASING ACROSS FEDERAL AGENCIES: A SOLUTION TO IMPROVE DRUG AFFORDABILITY IN MEDICARE PART D

    May 1, 2019, 00:00

  • PND8 THE EFFECT OF PHYSICAL ACTIVITY ON SLEEP QUALITY AMONG OLDER STROKE SURVIVORS: SECONDARY ANALYSIS FROM A RANDOMIZED CONTROLLED TRIAL

    May 1, 2019, 00:00

  • PCN264 QUALITY ADJUSTED TIME WITHOUT SYMPTOMS OF DISEASE PROGRESSION OR TOXICITY (Q-TWIST) OF NIVOLUMAB PLUS IPILIMUMAB (NIVO+IPI) VS SUNITINIB (SUN) AMONG UNTREATED ADVANCED RENAL CELL CARCINOMA (ARCC) PATIENTS (PATIENTS) WITH INTERMEDIATE ...

    May 1, 2019, 00:00

  • PCV35 BUDGET IMPACT ANALYSIS OF FIXED-DOSE ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE IN TREATMENT OF HEART FAILURE FROM A US MEDICARE POPULATION

    May 1, 2019, 00:00

  • PMH61 PATIENT SATISFACTION IN SUBSTANCE USE DISORDER TREATMENT: A SYSTEMATIC LITERATURE REVIEW

    May 1, 2019, 00:00

  • PMU103 THE DEVELOPMENT AND IMPLEMENTATION OF MOBILE APPLICATIONS FOR THE COLLECTION OF PATIENT EXPERIENCE DATA

    May 1, 2019, 00:00

  • Musculoskeletal Disorders - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PDB26 CONTRASTING THREE TYPE 2 DIABETES CARDIOVASCULAR RISK EQUATIONS FOR EAST ASIA WITH UKPDS82 USING THE IQVIA CORE DIABETES MODEL

    May 1, 2019, 00:00

  • PGI12 INCREASING TRENDS IN HEALTHCARE RESOURCE UTILIZATION AND MEDICATION USE OF ADULT CROHN’S DISEASE PATIENTS IN THE UNITED STATES, 2007-2017

    May 1, 2019, 00:00

  • PMD33 ECONOMIC BENEFITS OF POWERED AND TISSUE-SPECIFIC ENDOSCOPIC STAPLERS IN THE PATIENTS UNDERGOING VIDEO-ASSISTED THORACIC PULMONARY RESECTION

    May 1, 2019, 00:00

  • PIN79 ACCESS TO HCV CURE UNDER MEDICAID PROGRAMS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCV68 EFFECTS OF COCAINE ON THE CARDIOVASCULAR SYSTEM IN HUMANS

    May 1, 2019, 00:00

  • PCN306 REAL-WORLD STUDY OF HEALTHCARE UTILIZATION AND LONG-TERM PRODUCTIVITY LOSS IN CHRONIC GRAFT VERSUS HOST DISEASE IN SWEDEN

    May 1, 2019, 00:00

  • PIH6 PREVALENCE OF ADVERSE EVENTS AMONG CHILDREN TAKING MULTIPLE VERSUS SINGLE ANTIPSYCHOTICS

    May 1, 2019, 00:00

  • Cancer - Real World Data Information Systems

    May 1, 2019, 00:00

  • PMU17 BUDGET IMPACT OF SECUKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS IN MEXICO

    May 1, 2019, 00:00

  • Cancer - Medical Technologies

    May 1, 2019, 00:00

  • PMU112 HOW TO OPERATIONALISE A FULLY ANONYMISED RETROSPECTIVE CHART REVIEW. A CASE STUDY FOR THE DEVOLVED NATIONS OF THE UNITED KINGDOM

    May 1, 2019, 00:00

  • PCV45 ESTIMATE OF THE IMPACT AND COSTS OF CONGESTIVE HEART FAILURE FROM AN HEALTH PLAN IN BRAZIL: REAL WORLD SCENARIO STUDY

    May 1, 2019, 00:00

  • Neurological Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • Injury Trauma - Medical Technologies

    May 1, 2019, 00:00

  • Injury Process of Care

    May 1, 2019, 00:00

  • Individual's Health - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PNS128 IMPACT OF MEDICAID EXPANSION ON ACCESS TO CARE FOR CHILDREN OF PARENTS NEWLY ELIGIBLE TO RECEIVE MEDICAID BENEFITS

    May 1, 2019, 00:00

  • PDB57 REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPELTM STUDY

    May 1, 2019, 00:00

  • PCN243 REAL-TIME SYSTEMATIC LITERATURE REVIEWS (SLR) - DREAM OR REALITY WITH COMPUTER-ASSISTED METHODS: A CASE STUDY IN ACUTE MYELOID LEUKEMIA (AML)

    May 1, 2019, 00:00

  • PNS103 THE ASSOCIATION OF LIMITED ENGLISH PROFICIENCY (LEP) AND PHYSICIAN LANGUAGE CONCORDANCE ON PATIENTS’ PERCEIVED QUALITY OF CARE IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN280 REDUCTION IN PATIENT REPORTED BONE PAIN WITH PLINABULIN VS PEGFILGRASTIM IN NON SMALL CELL LUNG CANCER PATIENTS TREATED FOR THE PREVENTION OF DOCETAXEL-INDUCED NEUTROPENIA

    May 1, 2019, 00:00

  • PIN62 TWO DECADES OF HIV SCREENING IN AMERICA WITH CHANGING U.S. PREVENTIVE SERVICES TASK FORCE RECOMMENDATIONS; FINDINGS FROM 1997-2016 NATIONAL DATA

    May 1, 2019, 00:00

  • PDB44 INCREMENTAL HEALTHCARE EXPENDITURES ASSOCIATED WITH DYSLIPIDEMIA AMONG PATIENTS WITH THYROID DISEASES

    May 1, 2019, 00:00

  • PNS104 USE OF AN ADELPHI DISEASE SPECIFIC PROGRAMME TO ASSESS THE IMPACT OF INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW REPORT PUBLICATION ON SPECIALTY CATEGORY MANAGEMENT BY US INSURERS; A PHYSICIAN-BASED APPROACH

    May 1, 2019, 00:00

  • PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS

    May 1, 2019, 00:00

  • PNS119 IMPACT OF DIRECT-TO-CONSUMER DRUG ADVERTISING DURING THE SUPER BOWL ON DRUG UTILIZATION AND SPENDING

    May 1, 2019, 00:00

  • PDB73 WHAT IS THE LIFE-EXPECTANCY FOR DIABETICS IN BULGARIA?

    May 1, 2019, 00:00

  • PMU105 IMPACT OF BEHAVIORAL INTERVENTIONS FOR CHRONIC DISEASES ON HEALTH UTILITY: ASSESSMENT OF THREE TRIALS OF OLDER ADULTS

    May 1, 2019, 00:00

  • Exploring the Internal Structure of the EQ-5D Using Non–Preference-Based Methods

    May 1, 2019, 00:00

  • PNS242 THE DEVELOPMENT OF A NEW MEASUREMENT INSTRUMENT TO ASSESS HEALTH AND FUNCTIONING AMONG TOBACCO AND NICOTINE PRODUCT USERS: THE PREPARATORY PHASE

    May 1, 2019, 00:00

  • PNS177 A SYSTEMATIC REVIEW AND CONTENT ANALYSIS OF RHETORIC ABOUT THE INSTITUTE FOR CLINICAL AND ECONOMIC REVIEW (ICER) IN THE WRITTEN MEDIA, 2015-2017

    May 1, 2019, 00:00

  • Multiple Diseases - Organizational Practices

    May 1, 2019, 00:00

  • PMU51 IMPACT OF TREATMENT DELAYS ON PATIENT OUTCOMES AND IMPLICATIONS FOR MEDICARE POLICY

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Epidemiology Public Health

    May 1, 2019, 00:00

  • PNS38 THE VALUE OF PHARMACY INTEGRATION

    May 1, 2019, 00:00

  • PND49 DEMAND CHARACTERIZATION OF CHRONIC REHABILITATION SERVICES IN CHILDREN OF A HEALTH INSURER IN COLOMBIA

    May 1, 2019, 00:00

  • PNS35 IS NICE COST-EFFECTIVE?

    May 1, 2019, 00:00

  • PIN35 ECONOMIC ASSESSMENT OF A HIGH DOSE VERSUS A STANDARD DOSE INFLUENZA VACCINE IN THE US VETERAN POPULATION: ESTIMATING THE IMPACT ON HOSPITALIZATION COST FOR CARDIO-RESPIRATORY DISEASE

    May 1, 2019, 00:00

  • PCN289 DELAY OR FOREGO OF TREATMENT AND ASSOCIATED SERVICES IN PATIENTS WITH CANCER: A MEDICAL EXPENDITURE PANEL SURVEY (MEPS) STUDY

    May 1, 2019, 00:00

  • Copyright/Subscription

    May 1, 2019, 00:00

  • PIN56 EPIDEMIOLOGY OF HPV-RELATED CERVICAL LESIONS IN MID-ADULT WOMEN IN AFRICA

    May 1, 2019, 00:00

  • PMD22 COST-BENEFIT ANALYSIS OF BARIATRIC SURGERY FROM A PRIVATE AND PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE

    May 1, 2019, 00:00

  • PCN318 REAL WORLD TREATMENT DATA BASED PROJECTION OF PATIENT NUMBER ELIGIBLE FOR IMMUNO-ONCOLOGY THERAPIES IN TAIWAN AND ESTIMATION OF TOTAL LIFE YEARS GAINED

    May 1, 2019, 00:00

  • PMS46 OPIOID USAGE AND PATIENT-REPORTED PAIN SCORES IN RHEUMATOID ARTHRITIS PATIENTS: A RETROSPECTIVE ANALYSIS OF A LARGE US ELECTRONIC HEALTH RECORD DATABASE

    May 1, 2019, 00:00

  • PCN253 DECISION-MAKER PERSPECTIVES ON OUTCOMES STUDIED IN LEUKAEMIA CLINICAL TRIALS: THE RESPONSE EVALUATION IN LEUKAEMIA (REVALEU) STUDY PROTOCOL

    May 1, 2019, 00:00

  • PIH66 POLYCYSTIC OVARIAN SYNDROME (PCOS): A LITERATURE REVIEW OF THE POLYCYSTIC OVARY SYNDROME QUESTIONNAIRE (PCOSQ) FROM 2013-2018

    May 1, 2019, 00:00

  • PNS61 UNMET MEDICAL NEED AND HEALTH DISPARITIES AMONG U.S. ADULTS

    May 1, 2019, 00:00

  • PMH13 ESTIMATING THE BENEFIT OF LONG-ACTING INJECTABLES FOR SCHIZOPHRENIA TREATMENT IN RWANDA USING A ONE-YEAR COST-CONSEQUENCE MODEL

    May 1, 2019, 00:00

  • PNS95 DEMOGRAPHIC CHARACTERISTICS OF PATIENTS RECEIVING PRIVATELY FINANCED HEALTH CARE SERVICES IN HUNGARIAN PUBLICLY FINANCED HOSPITALS

    May 1, 2019, 00:00

  • PNS134 MEASUREMENT OF TURKISH HEALTH SYSTEM INDICATOR AMONG POPULATION HEALTHCARE SATISFACTION: CROSS SECTIONAL STUDY

    May 1, 2019, 00:00

  • PMH50 AFFECTING THE OPIOID CRISIS THROUGH OBSERVATIONAL RESEARCH: INSIGHTS FOR PREVENTION

    May 1, 2019, 00:00

  • PCV49 COST-EFFECTIVENESS OF ALIROCUMAB FOR PATIENTS WITH HYPERCHOLESTEROLEMIA AT HIGH CV RISK

    May 1, 2019, 00:00

  • PCN310 REAL WORLD SURVIVAL OUTCOMES WITH MODIFIED DOSE SCHEDULE OF BORTEZOMIB, MELPHALAN AND PREDNISONE IN PREVIOUSLY UNTREATED TRANSPLANT INELIGIBLE PATIENTS WITH MULTIPLE MYELOMA: A POPULATION BASED OBSERVATIONAL STUDY

    May 1, 2019, 00:00

  • PCV61 COMPARING ISCHAEMIC HEART DISEASE MORTALITY BETWEEN EASTERN AND WESTERN EUROPEAN COUNTRIES

    May 1, 2019, 00:00

  • PNS147 A FRAMEWORK FOR VETTING "GOOD” OUTCOMES-BASED MEASURES IN ALTERNATIVE PAYMENT MODELS

    May 1, 2019, 00:00

  • PNS142 INITIAL DEVELOPMENT OF AN INSTRUMENT TO ASSESS THE EFFECTIVENESS OF ACADEMIC DETAILING VISITS

    May 1, 2019, 00:00

  • PNS55 COST-BENEFIT ANALYSIS OF THREE TYPES LOW TEMPERATURE STERILIZATION SYSTEM: ETHYLENE OXIDE VERSUS FORMALDEHYDE VERSUS PEROXIDE PLASMA IN ENDOSCOPE STERILIZATION

    May 1, 2019, 00:00

  • PIN102 ARE LIVER-RELATED MORTALITY RATES DECREASING AFTER HEPATITIS B VACCINATION? CHALLENGES AND OPPORTUNITIES IN ASSESSING THE IMPACT OF HBV VACCINATION ON MORTALITY BY LIVER DISEASES IN DEVELOPING COUNTRIES. AN ECOLOGICAL ANALYSIS OF COL ...

    May 1, 2019, 00:00

  • PCN312 THE ECONOMIC BURDEN OF MELANOMA PATIENTS IN CHINA

    May 1, 2019, 00:00

  • PND34 ECONOMIC BURDEN OF PROBABLE LENNOX-GASTAUT SYNDROME, PROBABLE DRAVET SYNDROME, AND OTHER REFRACTORY EPILEPSIES FOR UNITED STATES MEDICAID HEALTH PLANS

    May 1, 2019, 00:00

  • PDB115 IMPACTS OF HYPOPARATHYROIDISM ON PATIENT WORK PRODUCTIVITY AND OUT-OF-POCKET COSTS

    May 1, 2019, 00:00

  • PNS39 INFLUENCING FACTORS AND FORMULARY CONSEQUENCES OF BUDGET IMPACT THRESHOLDS AS PERCEIVED BY PAYERS

    May 1, 2019, 00:00

  • PND81 PATIENT GLOBAL IMPRESSION OF CHANGE RELATED TO IMPROVEMENT IN MOST BOTHERSOME SYMPTOM FOLLOWING TREATMENT WITH EPTINEZUMAB

    May 1, 2019, 00:00

  • PIH71 HEALTH UTILITIES IN PEDIATRIC CANCER PATIENTS AND SURVIVORS: EVIDENCE FROM META-ANALYSIS

    May 1, 2019, 00:00

  • PMH63 A REAL WORLD ASSESSMENT OF OUTCOMES IN SCHIZOPHRENIA PATIENTS ACCORDING TO TREATMENT RESPONSE

    May 1, 2019, 00:00

  • PMD44 DISCRETE CHOICE PREFERENCES FOR PROSTHETIC INNOVATIONS IN PERSONS WITH UPPER LIMB LOSS

    May 1, 2019, 00:00

  • PMS29 COST-EFFECTIVENESS ANALYSIS OF CURRENT TREATMENT GUIDELINES FOR WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS IN THE US – A DISCRETE-EVENT SIMULATION MODEL

    May 1, 2019, 00:00

  • Injury Public Health

    May 1, 2019, 00:00

  • PNS93 IMPACT RESEARCH OF MEDICINE MARKUPS POLICY REFORM ON ECONOMIC OPERATION OF PUBLIC HOSPITALS IN A DISTRICT OF SHANGHAI

    May 1, 2019, 00:00

  • PMH49 FACILITY AND STATE-LEVEL FACTORS ASSOCIATED WITH TELEMENTAL HEALTH (TMH) ADOPTION AMONG MENTAL HEALTH FACILITIES IN THE UNITED STATES (US)

    May 1, 2019, 00:00

  • Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies

    May 1, 2019, 00:00

  • PNS159 A STUDY OF PUBLIC HEALTH INFRASTRUCTURE AND HEALTH MANPOWER OF SUB-CENTERS IN INDIA

    May 1, 2019, 00:00

  • PIT15 COMPLICATIONS, HEALTH RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH HARDWARE REMOVAL WITHIN 1-YEAR AFTER OPEN REDUCTION INTERNAL FIXATION OF HUMERUS FRACTURES

    May 1, 2019, 00:00

  • PDG46 PREVALENCE AND PREDICTORS OF POTENTIALLY INAPPROPRIATE MEDICATION PRESCRIBING FOR ELDERLY PATIENTS: A POPULATION-BASED CROSS-SECTIONAL STUDY

    May 1, 2019, 00:00

  • Multiple Diseases - Patient-Centered Research

    May 1, 2019, 00:00

  • NO Specific Disease - Health Technology Assessment

    May 1, 2019, 00:00

  • PND45 PHARMACOLOGICAL AND NON-PHARMACOLOGICAL STRATEGIES USED BY COMMUNITY DWELLING ADULTS TO MANAGE MIGRAINE: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PIH17 DIRECT COSTS OF MATERNAL CARE WITH PREECLAMPSIA: STANDARD AND OBSERVED COSTS IN COLOMBIA

    May 1, 2019, 00:00

  • PMD32 MINIMALLY INVASIVE VS OPEN SPINAL FUSION SURGERY: CLINICAL AND ECONOMIC PERIOPERATIVE EVALUATION IN A HOSPITAL BILLING DATABASE USING MATCHED COHORTS

    May 1, 2019, 00:00

  • PDB32 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN/METFORMIN EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CHINA

    May 1, 2019, 00:00

  • PDB41 TRENDS IN THE BURDEN OF OUT OF POCKET PAYMENTS IN DIABETES CARE: AN ANALYSIS OF THE MEDICAL EXPENDITURE PANEL SURVEY

    May 1, 2019, 00:00

  • PNS216 INCOME-ELASTICITY OF THE BODY MASS INDEX. RESULTS FROM A PERUVIAN HOUSEHOLD SURVEY

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PND35 ESTIMATE OF THE IMPACT AND COSTS OF MIGRAINE FROM AN HEALTH PLAN IN BRAZIL: REAL WORLD SCENARIO STUDY

    May 1, 2019, 00:00

  • PMD10 COST EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY FOR HEART FAILURE FROM A PUBLIC THIRD-PARTY PAYER PERSPECTIVE IN CHILE

    May 1, 2019, 00:00

  • PMU16 THE ESTIMATED ECONOMIC BURDEN OF CANCERS ATTRIBUTABLE TO SUBOPTIMAL DIET IN THE UNITED STATES

    May 1, 2019, 00:00

  • PCN291 ACUTE GRAFT VERSUS HOST DISEASE (GVHD), CHRONIC GVHD AND NON-RELAPSE MORTALITY (NRM) ASSOCIATED WITH MISMATCHED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT): A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PIH11 EXAMINING CERVICAL CANCER SCREENING INTERVALS AMONG WOMEN WITH NEWLY DIAGNOSED CERVICAL CANCER

    May 1, 2019, 00:00

  • PIN10 COSTS ASSOCIATED WITH FOODBORNE DISEASES IN A POOR POPULATION INSURED IN THE DEPARTMENT OF BOLIVAR, COLOMBIA

    May 1, 2019, 00:00

  • Individual's Health - Health Service Delivery Process of Care

    May 1, 2019, 00:00

  • PDG15 IMPACT OF USING REAL-WORLD OUTCOMES DATA VERSUS CLINICAL EVIDENCE AND PUBLISHED PRICES IN VALUE ASSESSMENTS

    May 1, 2019, 00:00

  • PIN96 DEVELOPMENT OF PATIENT-REPORTED OUTCOME (PRO) AND OBSERVER-REPORTED OUTCOME (OBSRO) MEASURES FOR ASSESSMENT OF SYMPTOM INTENSITY IN DENGUE ILLNESS

    May 1, 2019, 00:00

  • PDB84 LIVER BIOPSY - A BOTTLENECK TO NASH DIAGNOSIS

    May 1, 2019, 00:00

  • PIH26 HEALTHCARE RESOURCE UTILIZATION AND DIRECT MEDICAL COSTS ASSOCIATED WITH GENITAL WARTS IN DOMINICAN REPUBLIC

    May 1, 2019, 00:00

  • PNS174 INFLUENCING ICER: A REVIEW OF MANUFACTURER INVOLVEMENT IN ICER ASSESSMENTS

    May 1, 2019, 00:00

  • PMU10 MACHINE LEARNING APPROACHES TO FEATURE EXTRACTION WHEN PREDICTING MEDICATION COMPLIANCE AND PERSISTENCY

    May 1, 2019, 00:00

  • PIT13 IMPACT OF REOPERATIONS ON ONE-YEAR HEALTH CARE RESOURCE UTILIZATION AND COSTS AFTER INTRAMEDULLARY FIXATION OF PERTROCHANTERIC HIP FRACTURES

    May 1, 2019, 00:00

  • PND30 ECONOMIC EVALUATION OF ABOBOTULINUM TOXIN A VS ONABOTULINUM TOXIN A IN REAL-LIFE CLINICAL MANAGEMENT OF CERVICAL DYSTONIA

    May 1, 2019, 00:00

  • PMU38 ASSOCIATION OF PRESCRIPTION NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) WITH DEPRESSION AMONG ADULTS WITH INFLAMMATORY CHRONIC CONDITIONS IN THE UNITED STATES

    May 1, 2019, 00:00

  • PDB51 COST ANALYSIS COMPARING TWO HUMAN ALLOGRAFTS IN HEALING DIABETIC FOOT ULCERS OVER A 16 WEEK PERIOD

    May 1, 2019, 00:00

  • PDG65 FACTORS IMPACTING THE LIFE CYCLE OF GENERIC PRESCRIPTIONS

    May 1, 2019, 00:00

  • Drugs Generics - Conceptual Papers (CP)

    May 1, 2019, 00:00

  • PNS121 COMPARISON BETWEEN PRICING AND VOLUME CHANGE CONTRIBUTION TO THE TOTAL EXPENDITURE INCREASE: EXAMINING TRENDS AMONG VARIOUS TYPES OF MEDICAL SERVICE ITEMS

    May 1, 2019, 00:00

  • PMU94 QUANTIFYING THE HEALTH IMPACT AND RETURN ON INVESTMENT OF A HOME MEAL DELIVERY SERVICE USING SIMULATION MODELING

    May 1, 2019, 00:00

  • PNS238 DEVELOPMENT OF A PATIENT-FRIENDLY TRAINING ON HEALTH ECONOMICS AND VALUE ASSESSMENT

    May 1, 2019, 00:00

  • PNS234 HEALTH BEHAVIOR AND SUBJECTIVE HEALTH STATUS OF FOREIGN STUDENTS IN HUNGARY

    May 1, 2019, 00:00

  • PMU72 EVALUATION OF MEDICATION-RELATED PROBLEMS AMONG RURAL COMMUNITY-DWELLING PATIENTS RECEIVING MEDICATION THERAPY MANAGEMENT FOR DIABETES AND/OR HYPERTENSION

    May 1, 2019, 00:00

  • PDG14 TRENDS IN UTILIZATION, SPENDING, AND PRICES OF OPIOID MEDICATIONS IN THE US MEDICAID PROGRAMS 1991 - 2017

    May 1, 2019, 00:00

  • Medical Devices - Economic Evaluation

    May 1, 2019, 00:00

  • PCN287 ADJUVANT ANDROGEN THERAPY UTILIZATION AND ASSOCIATED OUTCOMES IN MEDICARE-ENROLLED ELDERLY PROSTATE CANCER SURVIVORS

    May 1, 2019, 00:00

  • PIT22 UNDERSTANDING PATIENT JOURNEY IN TERMS OF HEALTHCARE RESOURCE UTILIZATION (HCRU) AND COST OF CARE AMONG PATIENTS WITH THERMAL BURNS AND AUTOGRAFT IN A LARGE MANAGED CARE POPULATION

    May 1, 2019, 00:00

  • PCV56 COST- EFFECTIVENSS ANALYSIS OF COMBINING TRANDITIONAL CHINESE MEDICINE IN THE TREATMENT OF HYPERTENSION

    May 1, 2019, 00:00

  • PCV70 AMBULATORY BLOOD PRESSURE MONITORING IN THE DIAGNOSIS AND MANAGEMENT OF ARTERIAL HYPERTENSION IN CURRENT MEDICAL PRACTICE IN ALGERIA: MAPA DZ STUDY - FINAL ANALYSIS

    May 1, 2019, 00:00

  • PND24 CHARACTERISTICS AND OUTCOMES OF HOSPITALIZED PEDIATRIC MULTIPLE SCLEROSIS PATIENTS

    May 1, 2019, 00:00

  • PMD38 MUTUAL UNDERSTANDING BETWEEN SICKLE CELL DISEASE PATIENTS THAT REQUIRE BLOOD TRANSFUSION AND THEIR TREATING PHYSICIANS CONCERNING DRIVERS OF QUALITY OF LIFE

    May 1, 2019, 00:00

  • PDB88 THE IMPACT OF PHARMACIST-DELIVERED MEDICATION THERAPY MANAGEMENT (MTM) ON OUTCOMES FOR PATIENTS WITH DIABETES: A SYSTEMATIC REVIEW

    May 1, 2019, 00:00

  • PND37 COST-EFFECTIVENESS OF MIROGABALIN FOR THE TREATMENT OF POST-HERPETIC NEURALGIA IN TAIWAN

    May 1, 2019, 00:00

  • PDG26 BUDGET IMPACT ANALYSIS OF TOFACITINIB IN ADULT RHEUMATOID ARTHRITIS PATIENTS IN IRAQ

    May 1, 2019, 00:00

  • Cardiovascular Disorders - Methodological Statistical Research

    May 1, 2019, 00:00

  • PDG4 THE IMPACT OF ANTIBIOTIC TREATMENT TIME AND CLASS OF ANTIBIOTIC FOR ACUTE OTITIS MEDIA INFECTIONS ON THE RISK OF REVISITS

    May 1, 2019, 00:00

  • PMD19 ICD THERAPY FOR SUDDEN CARDIAC ARREST PREVENTION IS COST-EFFECTIVE IN THE 1.5 PREVENTION POPULATION IN BRAZIL

    May 1, 2019, 00:00

  • PNS101 YOU REAP WHAT YOU SOW; EUNETHTA COMING TO FRUITION

    May 1, 2019, 00:00

  • PDG48 POTENTIALLY INAPPROPRIATE PRESCRIPTIONS OF ANTICHOLINERGIC MEDICATIONS IN PATIENTS WITH CLOSED-ANGLE GLAUCOMA

    May 1, 2019, 00:00

  • PCV34 ANNUAL HEALTH INSURANCE TREATMENT COST OF PHLEBITIS AND THROMBOPHLEBITIS: A NATIONWIDE, REAL-WORLD COST OF ILLNESS STUDY

    May 1, 2019, 00:00

  • PCN309 REAL-WORLD CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA IN NORTH AMERICA AND EUROPE

    May 1, 2019, 00:00

  • PNS125 THE POLICY EFFECT OF MEDICAID EXPANSION ON POVERTY DISPARITY IN HEALTH INSURANCE COVERAGE

    May 1, 2019, 00:00

  • PIN2 BACTERIAL INFECTIONS CAUSED BY INTRAVENOUS SUPPLIES

    May 1, 2019, 00:00

  • PDG58 CLOSING THE MEDICARE PART D COVERAGE GAP: TRENDS IN DRUG UTILIZATION AND EXPENDITURES, 2008- 2015

    May 1, 2019, 00:00

  • PDG45 ENOXAPARIN AND LIVER INJURY: SIGNAL DETECTION USING DATA FROM FDA ADVERSE EVENT REPORTING SYSTEM (FEARS)

    May 1, 2019, 00:00

  • PCV28 THE OUT-OF-POCKET BURDEN OF AMBULATORY BLOOD PRESSURE MONITORING: A UNITED STATES PERSPECTIVE IN THE COMMERCIAL INSURANCE MARKETPLACE

    May 1, 2019, 00:00

  • PMH24 HEALTHCARE UTILIZATION AND COSTS ASSOCIATED WITH MENTAL HEALTH IN PATIENTS WITH OPIOID USE DISORDERS

    May 1, 2019, 00:00

  • Personalized Precision Medicine - Patient-Centered Research

    May 1, 2019, 00:00

  • PCN272 HUMANISTIC BURDEN OF BREAST, PROSTATE AND COLORECTAL CANCER IN JAPAN AND CHINA: A POPULATION BASED NHWS SURVEY

    May 1, 2019, 00:00

  • PNS71 HAEMOVIGILANCE AND ADVERSE REACTIONS FOLLOWING BLOOD TRANSFUSIONS: A CROSS SECTIONAL STUDY IN A DEVELOPING COUNTRY.

    May 1, 2019, 00:00

  • PNS75 THE QUALITY OF CARE WORKERS IN LONG-TERM CARE INSTITUTIONS IN ZHEJIANG PROVINCE, CHINA

    May 1, 2019, 00:00

  • PMH9 COST-EFFECTIVENESS OF WEB-BASED DEPRESSION PROGRAMS FOR ADOLESCENTS

    May 1, 2019, 00:00

  • Drugs Generics - Health Technology Assessment

    May 1, 2019, 00:00

  • PIN91 EFFICACY AND COST OF DAA THERAPY COMPARED WITH CLASSIC IFN THERAPY AMONG HCV PATIENTS IN CHINA: A REAL-WORLD STUDY

    May 1, 2019, 00:00

  • PCV20 LIMITATIONS OF ENTERIC-COATED ASPIRIN UNDERSCORE THE NEED FOR A NEXT GENERATION, SAFER AND EFFECTIVE ASPIRIN OPTION

    May 1, 2019, 00:00
  • «
  • 51
  • 52 (current)
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • »